RESUMO
OBJECTIVE: To study the effect, treatment course and adverse reactions of Ningmitai Capsules (NMT) in the treatment of chronic prostatitis (CP). METHODS: We searched the CNKI, Wanfang, COMDD and VIP databases, Cochrane Library, PubMed, EMBASE and Chinese academic conference papers for related articles before October 2019 on the treatment of CP with NMT, evaluated the quality of the literature with the Jadad Scale, and conducted a meta-analysis using the Stata14 software. RESULTS: Totally, 20 articles were included in this study, involving 3558 cases of CP, 1807 in the observation group and 1751 as controls. In the treatment of CP, NMT combined with quinolone, tetracycline or macrolide exhibited remarkably better effect than any of the above antibiotics used alone (RR ï¼»95% CIï¼½: 1.270 ï¼»1.215ï¼1.328ï¼½, 1.232 ï¼»1.132ï¼1.340ï¼½ and 1.239 ï¼»1.130ï¼1.359ï¼½, respectively) and the combination therapy also showed a higher total efficacy after 2, 4 and 8 weeks of medication (RR ï¼»95% CIï¼½: 1.256 ï¼»1.185ï¼1.330ï¼½, 1.245 ï¼»1.165ï¼1.330ï¼½ and 1.244 ï¼»1.131ï¼1.369ï¼½, respectively), though a little lower at 4 and 8 than at 2 weeks. There was no statistically significant difference in the incidence rate of adverse reactions between the NMT combination and antibiotics alone groups (P = 0.441). CONCLUSIONS: NMT combined with antibiotics, particularly with quinolone, is superior to antibiotics alone in the treatment of CP, though with no statistically significant difference in the incidence rate of adverse reactions between the two options. The length of medication does not inference the therapeutic effect.
